Search research articles
Contact Us
Filters
Showing results (291-300 of 484) with videos related to
Page
of 49
Sort By:
Arthritis Research & Therapy
|
April 18, 2015
Multiplex cytokine analysis of dermal interstitial blister fluid defines local disease mechanisms in systemic sclerosis
Kristina En Clark, Henry Lopez, Bahja Ahmed Abdi, et al.
The American Journal of Pathology
|
November 7, 2009
Keratinocyte-/fibroblast-targeted rescue of Col7a1-disrupted mice and generation of an exact dystrophic epidermolysis bullosa model using a human COL7A1 mutation
Kei Ito, Daisuke Sawamura, Maki Goto, et al.
The Lancet. Infectious Diseases
|
March 11, 2021
Chilblain-like acral lesions in long COVID-19: management and implications for understanding microangiopathy
Puja Mehta, Christopher B Bunker, Coziana Ciurtin, et al.
Rheumatology (Oxford, England)
|
May 21, 2025
Evaluating the relevance of the 2024 BSR systemic sclerosis guideline to juvenile systemic sclerosis
Clare E Pain, Hanna Lythgoe, Emily Willis, et al.
Annals of the Rheumatic Diseases
|
January 20, 2018
Changes in macrophage transcriptome associate with systemic sclerosis and mediate <i>GSDMA</i> contribution to disease risk
Aida Moreno-Moral, Marta Bagnati, Surya Koturan, et al.
Scientific Reports
|
June 3, 2017
Use of Patterned Collagen Coated Slides to Study Normal and Scleroderma Lung Fibroblast Migration
Bahja Ahmed Abdi, Henry Lopez, Sarah Karrar, et al.
Rheumatology (Oxford, England)
|
July 23, 2023
Construct validity and reliability of the Assessment of Systemic Sclerosis-Associated Raynaud's Phenomenon (ASRAP) questionnaire
John D Pauling, Lan Yu, Tracy M Frech, et al.
Arthritis and Rheumatism
|
December 30, 2006
Postnatal induction of transforming growth factor beta signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma
Sonali Sonnylal, Christopher P Denton, Bing Zheng, et al.
Arthritis Research & Therapy
|
September 7, 2021
The pan-PPAR agonist lanifibranor reduces development of lung fibrosis and attenuates cardiorespiratory manifestations in a transgenic mouse model of systemic sclerosis
Emma Derrett-Smith, Kristina E N Clark, Xu Shiwen, et al.
Arthritis Care & Research
|
October 10, 2022
Assessment of the Systemic Sclerosis-Associated Raynaud's Phenomenon Questionnaire: Item Bank and Short-Form Development
Lan Yu, Robyn T Domsic, Lesley-Ann Saketkoo, et al.
Page
of 49
Search research articles
Search
Showing results (291-300 of 484) with videos related to
Sort By:
Page
of 49
Arthritis Research & Therapy
|
April 18, 2015
Multiplex cytokine analysis of dermal interstitial blister fluid defines local disease mechanisms in systemic sclerosis
Kristina En Clark, Henry Lopez, Bahja Ahmed Abdi, et al.
The American Journal of Pathology
|
November 7, 2009
Keratinocyte-/fibroblast-targeted rescue of Col7a1-disrupted mice and generation of an exact dystrophic epidermolysis bullosa model using a human COL7A1 mutation
Kei Ito, Daisuke Sawamura, Maki Goto, et al.
The Lancet. Infectious Diseases
|
March 11, 2021
Chilblain-like acral lesions in long COVID-19: management and implications for understanding microangiopathy
Puja Mehta, Christopher B Bunker, Coziana Ciurtin, et al.
Rheumatology (Oxford, England)
|
May 21, 2025
Evaluating the relevance of the 2024 BSR systemic sclerosis guideline to juvenile systemic sclerosis
Clare E Pain, Hanna Lythgoe, Emily Willis, et al.
Annals of the Rheumatic Diseases
|
January 20, 2018
Changes in macrophage transcriptome associate with systemic sclerosis and mediate <i>GSDMA</i> contribution to disease risk
Aida Moreno-Moral, Marta Bagnati, Surya Koturan, et al.
Scientific Reports
|
June 3, 2017
Use of Patterned Collagen Coated Slides to Study Normal and Scleroderma Lung Fibroblast Migration
Bahja Ahmed Abdi, Henry Lopez, Sarah Karrar, et al.
Rheumatology (Oxford, England)
|
July 23, 2023
Construct validity and reliability of the Assessment of Systemic Sclerosis-Associated Raynaud's Phenomenon (ASRAP) questionnaire
John D Pauling, Lan Yu, Tracy M Frech, et al.
Arthritis and Rheumatism
|
December 30, 2006
Postnatal induction of transforming growth factor beta signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma
Sonali Sonnylal, Christopher P Denton, Bing Zheng, et al.
Arthritis Research & Therapy
|
September 7, 2021
The pan-PPAR agonist lanifibranor reduces development of lung fibrosis and attenuates cardiorespiratory manifestations in a transgenic mouse model of systemic sclerosis
Emma Derrett-Smith, Kristina E N Clark, Xu Shiwen, et al.
Arthritis Care & Research
|
October 10, 2022
Assessment of the Systemic Sclerosis-Associated Raynaud's Phenomenon Questionnaire: Item Bank and Short-Form Development
Lan Yu, Robyn T Domsic, Lesley-Ann Saketkoo, et al.
Page
of 49